Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

372 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Targeting CCR7-PI3Kγ overcomes resistance to tyrosine kinase inhibitors in ALK-rearranged lymphoma.
Mastini C, Campisi M, Patrucco E, Mura G, Ferreira A, Costa C, Ambrogio C, Germena G, Martinengo C, Peola S, Mota I, Vissio E, Molinaro L, Arigoni M, Olivero M, Calogero R, Prokoph N, Tabbò F, Shoji B, Brugieres L, Geoerger B, Turner SD, Cuesta-Mateos C, D'Aliberti D, Mologni L, Piazza R, Gambacorti-Passerini C, Inghirami GG, Chiono V, Kamm RD, Hirsch E, Koch R, Weinstock DM, Aster JC, Voena C, Chiarle R. Mastini C, et al. Sci Transl Med. 2023 Jun 28;15(702):eabo3826. doi: 10.1126/scitranslmed.abo3826. Epub 2023 Jun 28. Sci Transl Med. 2023. PMID: 37379367 Free PMC article.
Recurrent somatic mutations of FAT family cadherins induce an aggressive phenotype and poor prognosis in anaplastic large cell lymphoma.
Villa M, Sharma GG, Malighetti F, Mauri M, Arosio G, Cordani N, Lobello C, Larose H, Pirola A, D'Aliberti D, Massimino L, Criscuolo L, Pagani L, Chinello C, Mastini C, Fontana D, Bombelli S, Meneveri R, Lovisa F, Mussolin L, Janikova A, Pospíšilová Š, Turner SD, Inghirami G, Magni F, Urso M, Pagni F, Ramazzotti D, Piazza R, Chiarle R, Gambacorti-Passerini C, Mologni L. Villa M, et al. Among authors: gambacorti passerini c. Br J Cancer. 2024 Dec;131(11):1781-1795. doi: 10.1038/s41416-024-02881-7. Epub 2024 Oct 30. Br J Cancer. 2024. PMID: 39478125
Pathway and network analysis of more than 2500 whole cancer genomes.
Reyna MA, Haan D, Paczkowska M, Verbeke LPC, Vazquez M, Kahraman A, Pulido-Tamayo S, Barenboim J, Wadi L, Dhingra P, Shrestha R, Getz G, Lawrence MS, Pedersen JS, Rubin MA, Wheeler DA, Brunak S, Izarzugaza JMG, Khurana E, Marchal K, von Mering C, Sahinalp SC, Valencia A; PCAWG Drivers and Functional Interpretation Working Group; Reimand J, Stuart JM, Raphael BJ; PCAWG Consortium. Reyna MA, et al. Nat Commun. 2020 Feb 5;11(1):729. doi: 10.1038/s41467-020-14367-0. Nat Commun. 2020. PMID: 32024854 Free PMC article.
Direct determination of chronic myeloid leukemia prevalence in Lombardy-Italy: Global implications.
Polverelli N, Anghilieri M, Elena C, Intermesoli T, Pungolino E, D'Adda M, Iurlo A, Maffioli M, Lunghi F, Bertolli V, Orofino N, Sissa C, Fiamenghi C, Gardellini A, Ubezio M, Carraro MC, Corradini P, Giglio F, Pasquini MC, Palazzolo R, Calori R, Ercolanoni M, Gambacorti-Passerini C. Polverelli N, et al. Among authors: gambacorti passerini c. Hematol Oncol. 2024 Sep;42(5):e3311. doi: 10.1002/hon.3311. Hematol Oncol. 2024. PMID: 39305481
Bosutinib Treatment of Chronic Myeloid Leukemia in Lombardy.
Iurlo A, Bucelli C, Intermesoli T, Elena C, D'Adda M, Agostani E, Fiamenghi C, Maffioli M, Orofino N, Lunghi F, Gardellini A, Carraro MC, Inzoli A, Gigli F, Palazzolo R, Bertolli V, Cattaneo D, Pungolino EM, Gambacorti-Passerini C. Iurlo A, et al. Among authors: gambacorti passerini c. Acta Haematol. 2024 Sep 18:1-5. doi: 10.1159/000540572. Online ahead of print. Acta Haematol. 2024. PMID: 39293408
Hairy cell leukemia with an atypical extranodal presentation: A clinicopathological analysis of four cases.
Sangiorgio V, Palasciano A, Tabanelli V, Giné E, Guerra L, Pagni F, Casiraghi A, Casaroli I, Frigola G, Magnano L, Gambacorti-Passerini C, Derenzini E, Vanazzi A, Campo E. Sangiorgio V, et al. Among authors: gambacorti passerini c. Hum Pathol. 2024 Oct;152:105651. doi: 10.1016/j.humpath.2024.105651. Epub 2024 Aug 28. Hum Pathol. 2024. PMID: 39214241 No abstract available.
Efficacy and safety of bosutinib in previously treated patients with chronic myeloid leukemia: final results from the BYOND trial.
Gambacorti-Passerini C, Brümmendorf TH, Abruzzese E, Kelly KR, Oehler VG, García-Gutiérrez V, Hjorth-Hansen H, Ernst T, Leip E, Purcell S, Luscan G, Viqueira A, Giles FJ, Hochhaus A. Gambacorti-Passerini C, et al. Leukemia. 2024 Oct;38(10):2162-2170. doi: 10.1038/s41375-024-02372-x. Epub 2024 Aug 20. Leukemia. 2024. PMID: 39164407 Free PMC article. Clinical Trial.
372 results